Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients

Table 8 Log-rank test to compare the cumulative incidence of post-transplant cutaneous squamous cell carcinoma between different risk groups where patients were divided using the scoring system without OKT3 and daclizumab

Group	P value	Hazard ratio (95%CI)
Low vs very low	< 0.001	3.97 (3.51-4.50)
Medium vs very low	< 0.001	6.80 (5.86-7.90)
Medium vs low	< 0.001	1.70 (1.52-1.90)
High vs very low	< 0.001	10.1 (5.41-18.8)
High vs low	< 0.001	2.48 (1.78-3.47)
High vs medium	0.003	1.41 (1.09-1.83)

CI: Confidence interval.